Cargando…

Leukotriene B(4)-loaded microspheres: a new therapeutic strategy to modulate cell activation

BACKGROUND: Leukotriene B(4 )(LTB(4)) is a potent inflammatory mediator that also stimulates the immune response. In addition, it promotes polymorphonuclear leukocyte phagocytosis, chemotaxis, chemokinesis and modulates cytokines release. Regarding chemical instability of the leukotriene molecule, i...

Descripción completa

Detalles Bibliográficos
Autores principales: Nicolete, Roberto, Rius, Cristina, Piqueras, Laura, Jose, Peter J, Sorgi, Carlos A, Soares, Edson G, Sanz, Maria J, Faccioli, Lúcia H
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2483258/
https://www.ncbi.nlm.nih.gov/pubmed/18627613
http://dx.doi.org/10.1186/1471-2172-9-36
_version_ 1782158009681575936
author Nicolete, Roberto
Rius, Cristina
Piqueras, Laura
Jose, Peter J
Sorgi, Carlos A
Soares, Edson G
Sanz, Maria J
Faccioli, Lúcia H
author_facet Nicolete, Roberto
Rius, Cristina
Piqueras, Laura
Jose, Peter J
Sorgi, Carlos A
Soares, Edson G
Sanz, Maria J
Faccioli, Lúcia H
author_sort Nicolete, Roberto
collection PubMed
description BACKGROUND: Leukotriene B(4 )(LTB(4)) is a potent inflammatory mediator that also stimulates the immune response. In addition, it promotes polymorphonuclear leukocyte phagocytosis, chemotaxis, chemokinesis and modulates cytokines release. Regarding chemical instability of the leukotriene molecule, in the present study we assessed the immunomodulatory activities conferred by LTB(4 )released from microspheres (MS). A previous oil-in-water emulsion solvent extraction-evaporation method was chosen to prepare LTB(4)-loaded MS. RESULTS: In the mice cremasteric microcirculation, intraescrotal injection of 0.1 ml of LTB(4)-loaded MS provoked significant increases in leukocyte rolling flux, adhesion and emigration besides significant decreases in the leukocyte rolling velocity. LTB(4)-loaded MS also increase peroxisome proliferator-activated receptor-α (PPARα) expression by murine peritoneal macrophages and stimulate them to generate nitrite levels. Monocyte chemoattractant protein-1 (MCP-1) and nitric oxide (NO) productions were also increased when human umbilical vein and artery endothelial cells (HUVECs and HUAECs, respectively) were stimulated with LTB(4)-loaded MS. CONCLUSION: LTB(4)-loaded MS preserve the biological activity of the encapsulated mediator indicating their use as a new strategy to modulate cell activation, especially in the innate immune response.
format Text
id pubmed-2483258
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-24832582008-07-24 Leukotriene B(4)-loaded microspheres: a new therapeutic strategy to modulate cell activation Nicolete, Roberto Rius, Cristina Piqueras, Laura Jose, Peter J Sorgi, Carlos A Soares, Edson G Sanz, Maria J Faccioli, Lúcia H BMC Immunol Research Article BACKGROUND: Leukotriene B(4 )(LTB(4)) is a potent inflammatory mediator that also stimulates the immune response. In addition, it promotes polymorphonuclear leukocyte phagocytosis, chemotaxis, chemokinesis and modulates cytokines release. Regarding chemical instability of the leukotriene molecule, in the present study we assessed the immunomodulatory activities conferred by LTB(4 )released from microspheres (MS). A previous oil-in-water emulsion solvent extraction-evaporation method was chosen to prepare LTB(4)-loaded MS. RESULTS: In the mice cremasteric microcirculation, intraescrotal injection of 0.1 ml of LTB(4)-loaded MS provoked significant increases in leukocyte rolling flux, adhesion and emigration besides significant decreases in the leukocyte rolling velocity. LTB(4)-loaded MS also increase peroxisome proliferator-activated receptor-α (PPARα) expression by murine peritoneal macrophages and stimulate them to generate nitrite levels. Monocyte chemoattractant protein-1 (MCP-1) and nitric oxide (NO) productions were also increased when human umbilical vein and artery endothelial cells (HUVECs and HUAECs, respectively) were stimulated with LTB(4)-loaded MS. CONCLUSION: LTB(4)-loaded MS preserve the biological activity of the encapsulated mediator indicating their use as a new strategy to modulate cell activation, especially in the innate immune response. BioMed Central 2008-07-15 /pmc/articles/PMC2483258/ /pubmed/18627613 http://dx.doi.org/10.1186/1471-2172-9-36 Text en Copyright © 2008 Nicolete et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Nicolete, Roberto
Rius, Cristina
Piqueras, Laura
Jose, Peter J
Sorgi, Carlos A
Soares, Edson G
Sanz, Maria J
Faccioli, Lúcia H
Leukotriene B(4)-loaded microspheres: a new therapeutic strategy to modulate cell activation
title Leukotriene B(4)-loaded microspheres: a new therapeutic strategy to modulate cell activation
title_full Leukotriene B(4)-loaded microspheres: a new therapeutic strategy to modulate cell activation
title_fullStr Leukotriene B(4)-loaded microspheres: a new therapeutic strategy to modulate cell activation
title_full_unstemmed Leukotriene B(4)-loaded microspheres: a new therapeutic strategy to modulate cell activation
title_short Leukotriene B(4)-loaded microspheres: a new therapeutic strategy to modulate cell activation
title_sort leukotriene b(4)-loaded microspheres: a new therapeutic strategy to modulate cell activation
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2483258/
https://www.ncbi.nlm.nih.gov/pubmed/18627613
http://dx.doi.org/10.1186/1471-2172-9-36
work_keys_str_mv AT nicoleteroberto leukotrieneb4loadedmicrospheresanewtherapeuticstrategytomodulatecellactivation
AT riuscristina leukotrieneb4loadedmicrospheresanewtherapeuticstrategytomodulatecellactivation
AT piqueraslaura leukotrieneb4loadedmicrospheresanewtherapeuticstrategytomodulatecellactivation
AT josepeterj leukotrieneb4loadedmicrospheresanewtherapeuticstrategytomodulatecellactivation
AT sorgicarlosa leukotrieneb4loadedmicrospheresanewtherapeuticstrategytomodulatecellactivation
AT soaresedsong leukotrieneb4loadedmicrospheresanewtherapeuticstrategytomodulatecellactivation
AT sanzmariaj leukotrieneb4loadedmicrospheresanewtherapeuticstrategytomodulatecellactivation
AT faccioliluciah leukotrieneb4loadedmicrospheresanewtherapeuticstrategytomodulatecellactivation